Journal of IMAB - Annual Proceeding (Scientific Papers) Oct-Dec;23(4) Original article
|
|
- Doreen Bryant
- 5 years ago
- Views:
Transcription
1 Journal of IMAB ISSN: X Journal of IMAB - Annual Proceeding (Scientific Papers) Oct-Dec;23(4) Original article ANTIMICROBIAL SUSCEPTIBILITY OF CLINICALLY SIGNIFICANT ISOLATES OF ENTEROBACTER SPP., OBTAINED FROM PATIENTS, HOSPITALISED IN VARNA UNIVERSITY HOSPITAL DURING THE PERIOD Dobromira Dimitrova 1, Temenuga Stoeva 1, Rumyana Markovska 2, Petya Stankova 2, Milena Bozhkova 1, Gergana Nedelcheva 1, Ivan Mitov 2 1) Department of Microbiology and Virology, Medical University, Varna 2) Department of Medical Microbiology, Medical University, Sofia, Bulgaria. ABSTRACT Purpose: Rapidly increasing antimicrobial resistance in medically important bacterial species from family Enterobacteriaceae is one of the most significant microbiological, clinical and epidemiological issues of modern medicine. The aim of this study is to investigate the antibiotic susceptibility of clinically significant isolates of Enterobacter spp., obtained from patients, hospitalized in University Hospital Saint Marina Varna during the period Material and methods: a total of 433 clinical isolates of Enterobacter spp. from blood cultures, urine and wound secretions were studied. The species identification was made by conventional, semi-automated (Crystal, BD) and automated systems (Phoenix, BD). The susceptibility to piperacillin/tazobactam (TZP), ceftazidime (CAZ), meropenem (MEM), gentamicin (Gm), amikacin (Ak), ciprofloxacin (CIP), levofloxacin (LVX), trimethoprime/ sulfamethoxazole (SXT) and tetracycline (Tet) was tested by disc-diffusion method and / or automated system Phoenix 100, BD. The results were interpreted according to EUCAST 2016 guidelines. Results: The resistance in the studied collection of isolates, shown in increasing order is as follows: Ak, 4.2% < LVF, 25.4% < TZP, 37.4% < Tet, 38.7% < SXT, 40% < CIP, 44.1% < Gm, 49.7% < CAZ, 57%. Meropenem demonstrated fully preserved activity. In the group of CAZ resistant isolates, the levels of antimicrobial resistance are: Ak, 5.7% < LVF, 42.9% < Tet, 52.4% < SXT, 60.3% < TZP, 64.4% < CIP, 84.6% < Gm, 86.2%. The rate of CAZ resistant Enterobacter spp. was 66.9% among the urine isolates, 61.9% - among those from blood culture and 46.3% - in the group of isolates from wound secretions. In the three mentioned groups of isolates, the lowest level of resistance was detected to Ak (1.6%; 4%; 6.9%). The isolates from wound and blood cultures demonstrated the highest level of resistance to Gm (60.3%, 42.9%) and the urine isolates to Tet (60%) and CIP (56.9%). Conclusions: CAZ resistant Enterobacter spp. demonstrated significantly higher levels of resistance in comparison to the whole studied group especially to quinolones and aminoglycosides. The highest level of CAZ resistant Enterobacter spp. was detected in the group of urine isolates. Keywords: Enterobacter spp., antimicrobial susceptibility, resistance. INTRODUCTION Species from genus Enterobacter are ubiquitous bacteria, widely distributed in nature. They are part of the normal enteric flora of humans and animals but also can cause nosocomial infections predominantly in immunocompromized patients and patients from the ICUs [1, 2]. Recently, a selected group of bacteria has been described by the acronym of ESKAPE, and they cause most of the healthcare-associated infections: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species. These bacteria are clinically important not only because are causative agents of nosocomial infections but also because are a paradigm for pathogenesis, transmission and resistance [3]. Bacteria from genus Enterobacter are associated predominantly with bacteremia, pneumonia, urinary tract and intra-abdominal infections, endocarditis, skin and soft tissue infections [1]. Enterobacter species are with intrinsic resistance to aminopenicillins, amoxicillin/clavulanic acid, cefoxitin and first-generation cephalosporins because of the production of chromosomally encoded, inducible Amp C â- lactamase [1, 4, 5]. This enzyme does not hydrolyse carboxy- and ureidopenicillins, II, III and IV generation cephalosporins and carbapenems [4, 5]. During the last decades Enterobacter isolates, resistant to extended spectrum cephalosporins have been reported more frequently [1, 4]. Usually, these isolates are associated with the production of plasmid encoded Extended Spectrum Beta Lactamases (ESBLs) and/or derepressed production of Amp C enzymes J of IMAB Oct-Dec;23(4)
2 [1, 4]. The ESBLs are most widely dessiminated, and cause hydrolyses to penicillins and all generations cephalospoirins [6, 7]. Such isolates of Enterobacter spp. demonstrate very often cross-resistance to other antimicrobial agents - aminoglycosides, quinolones, trimethoprim/sulphamothoxazole, etc. [8]. The resistance to β-lactams, quinolones, aminoglycosides, trimethoprim/sulphamothoxazole is higher in the European, Asian and some countries in South America than in the USA and Canada [9, 10]. Very worrisome is the fact that worldwide carbapenem-resistant isolates of Enterobacter have been reported with increasing frequency [1, 4]. The study aimed to investigate the antimicrobial susceptibility of a collection of clinically significant isolates of Enterobacter spp., obtained from patients, hospitalized in the University Hospital Saint Marina Varna, Bulgaria during the period MATERIALS AND METHODS Between January 2014 and December 2016, a total of 433 clinically significant Enterobacter spp. isolates were collected from patients, hospitalized in different wards of the University Hospital Saint Marina in Varna, Bulgaria. The isolates were recovered from various clinical specimens: urine samples - 130; blood - 126; wound secretions Species identification was made by the semi-automated and automated systems Crystal (BD) and Phoenix 100 (BD). Antimicrobial susceptibility to set of antimicrobial agents (ceftazidime, meropenem, tetracycline, gentamicin, amikacin, trimethoprime/sulphometoxazole, ciprofloxacin, levofloxacin) was determined by disk - diffusion method and/or by the automated system Phoenix 100 (BD). The results were interpreted according to EUCAST 2016 guidelines [11]. RESULTS The results from the antimicrobial susceptibilty testing are presented on Figures 1, 2 and 3. The antimicrobial resistance in the whole collection of isolates (n=433), shown in increasing order, is as follows: amikacin, 4.2% < levofloxacin, 25.4% < piperacillin/ tazobactam, 37.4% < tetracycline, 38.7% < trimethoprime/ sulphometoxazole, 40% < ciprofloxacin, 44.1% < gentamicin, 49.7% < ceftazidime, 57%. Meropenem demonstrated fully preserved activity (no resistance detected) (Figure 1). Fig. 1. Antimicrobial resistance in the whole collection of Enterobacter spp. isolates (n=433) CAZ - ceftazidime, TZP piperacillin/tazobactam, Gm - gentamicin, Ak - amikacin, T - tetracycline, SXT - trimethoprime/sulphometoxazole, CIP - ciprofloxacin, LVX levofloxacin. In the group of ceftazidime resistant isolates (n=247), the levels of antimicrobial resistance, presented in increasing order, are as follows: amikacin, 5.7% < levofoxacin, 42.9% < tetracycline, 52.4% < trimethoprime/sulphometoxazole, 60.3% < piperacillin/tazobactam, 64.4% < ciprofloxacin, 84.6% < gentamicin, 86.2% (Figure 2). J of IMAB Oct-Dec;23(4)
3 Fig. 2. Antimicrobial resistance of 247 clinical isolates of Enterobacter spp., resistant to ceftazidime (%). CAZ - ceftazidime, TZP piperacillin/tazobactam, Gm - gentamicin, Ak - amikacin, T - tetracycline, SXT - trimethoprime/sulphometoxazole, CIP - ciprofloxacin, LVX - levofloxacin. Antimicrobial resistance of the tested isolates according to their site of isolation is presented on Figure 3. (%). Fig. 3. Antimicrobial resistance of 433 clinical isolates of Enterobacter spp. according to their site of isolation CAZ - ceftazidime, TZP piperacillin/tazobactam, Gm - gentamicin, Ak - amikacin, T - tetracycline, SXT - trimethoprime/sulphometoxazole, CIP - ciprofloxacin, LVX - levofloxacin. A total of 126 isolates of Enterobacter spp. were obtained from blood cultures. The resistance rate to III generation cephalosporins was 61.9%. The resistance to piperacillin/tazobactam was 50% and above 40% for ciprofloxacin (49.2%), tetracycline (50.9%), trimethoprime/sulphometoxazole (52.4%) and gentamicin (60%) (figure 3). The most active antimicrobial agents were meropenem (100% susceptibility), amikacin (98.4%) and levofloxacin (86.1%). In the group of ceftazidime resistant isolates from blood cultures, the levels of antimicrobial resistance, presented in increasing order, were as follows: levofoxacin, 25.4% < trimethoprime/sulphometoxazole, 60.7% < tetracycline, 75% < piperacillin/tazobactam, 81.5% < ciprofloxacin, 85.0% < gentamicin, 90.0%. A total of 130 isolates of Enterobacter spp. were obtained from urine samples. The resistance rate to III generation cephalosporins was 66.9%. The resistance to piperacillin/tazobactam was 39.2% and above 40% for trimethoprime/sulphometoxazole (48.5%), levofloxacin (48.5%), gentamicin (52.3%), ciprofloxacin (56.9%) and tetracycline (60%). Lowest resistance rate was detected for meropenem (0%) and amikacin (6.9%) (Figure 3). A total of 177 isolates of Enterobacter spp. were obtained from wound secretions. The resistance rate to III generation cephalosporins was 46.3%. The resistance to piperacillin/tazobactam was 27.1% and above 30% for trimethoprime/sulphometoxazole (31.6%), ciprofloxacin (31.1%), tetracycline (37.5%) and gentamicin (42.9%) (Figure 3). The most active antimicrobial agents were meropenem (100% susceptibility), amikacin (96%) and levofloxacin (83.1%) J of IMAB Oct-Dec;23(4)
4 DISCUSSION During the last decade, the species from genus Enterobacter are among the fifth most commonly isolated bacterial species from clinical materials worldwide [2, 4]. In Varna University Hospital Saint Marina, Enterobacter cloacae takes the second place as a causitive agent of bacteremia for 2015 and the fourth place for 2016 (not published data). Our results demonstrate a worrisome increase of resistance to beta-lactam antibiotics: 57% of the isolates were resistant to III generation cephalosporins (ceftazidime) and 37.4% to piperacillin/tazobactam. High resistance levels (above 25%) were detected for quinolones, gentamicin, tetracycline and trimethoprime/sulphometoxazole. The most active antimicrobial agents were meropenem (no resistant isolates found) and amikacin (4.2%). For a collection of 177 isolates of Enterobacter spp. Xie et al. reported similar to our results regarding ceftazidime and amikacin resistance levels: 40% and 3.6% respectively [12]. These authors reported lower levels of resistance to other groups of antimicrobial agents: ciprofloxacin, 16.7%; levofloxacin, 10.5%; gentamicin, 15%; piperacillin/tazobactam, 6.8%; cefepime, 17.3% and trimethoprime/sulphometoxazole, 29.4%. The resistance to imipenem and meropenem was 14.5% and 13.2% respectively [12]. In a recent study, Maraki et al. investigated the susceptibility and the resistance phenotype of 939 isolates of Enterobacter spp., collected during a 6-year period ( ) [13]. The most active antimicrobial agents in this study were colistin (97.9% susceptibilty), followed by imipenem (96.1%) and gentamicin (95.7%). Resistance to beta-lactams was lower than our results with the exception of carbapenems: piperacillin/tazobactam, 26.0%; ceftazidime, 25.7%; cefepime, 10.2%; imipenem, 3.4%; meropenem, 6.3%. The authors reported low resistance levels to amikacin, 4.2%; gentamicin, 2.8%; ciprofloxacin, 6.4%; levofloxacin, 6.1% and trimethoprime/sulphometoxazole, 11.1% [13]. In these reports, the resistance to III and IV generation cephalosporins is found to be associated predominantly with Amp C, and all isolates are determined as multi-drug resistant (MDR) [13, 14]. In a recent study performed in our hospital in 2014, the ESBLs production in clinical isolates of Enterobacter spp., collected during the period from hospitalized patients was investigated. An increasing level of ESBL - producing Enterobacter spp. was detected: from 28% in 2007 ã. to 36% and 39% in 2010 and 2011 [15]. This was followed by the current study where we detected 57% ceftazidime resistant isolates. This result shows the need for urgent infection control measures. In the present study higher levels of resistance to all tested antimicrobials were detected in the group of ceftazidime resistant isolates. This result probably is associated with the possible production of plasmid mediated ESBLs or/and Amp C production. Different types of plasmids, identified in family Enterobacteriaceae, play an important role in the dissemination of ESBL genes [16, 17]. Some of these plasmids (IncFI, IncFII, Inc A/C, Inc M/L and IncHI2) carry not only ESBLs genes, but also genes, that encode plasmid-mediated quinolone resistance (qnr, aac (6')-Ib-cr, qepa, oqxab) and genes, associated with resistance to other antimicrobial agents (aminoglycosides, trimethoprime/sulfametoxazole) [6, 9, 18, 19, 20, 21, 22, 23, 24]. This fact explains the common association of ceftazidime resistance (an indicator for ESBLs or/and AmpC production) with the resistance to other antimicrobial groups and the MDR phenotype, usually exhibited by these isolates. The antimicrobial resistance of the studied isolates varied according to their site of isolation (blood, urine and wound secretions). The urine isolates were more resistant to most of the tested antimicrobial agents: ceftazidime (66.9%), amikacin (6.9%), ciprofloxacin (56.9%), levofloxacin (48.5%) and tetracycline (60%). As part of SMART Program , Karlowsky et al. report the following rates of resistance among 165 isolates of Enterobacter spp. isolated from hospitalized patients with urinary tract infections in Latin American countries: ceftazidime %, cefepime %, amikacin - 4.9%, imipenem - 7.3%, levofloxacin %, piperacillin/ tazobactam % [25]. A similar study on 154 isolates of Enterobacter spp., isolated from hospitalized patients with urinary tract infections in Asia - Pacific countries during the period , demonstrates similar levels of resistance: ceftazidime %, cefepime %, amikacin - 8.4%, imipenem - 6.5%, levofloxacin %, piperacillin/tazobactam % [26]. In contrast to these studies, we detected higher rates of resistance to extended spectrum cephalosporins (66.9%) and the quinolones ciprofloxacin (56.9%) and levofloxacin (48.5%). Similar to the urine isolates, high levels of resistance to all tested antimicrobials were also detected in the group of blood culture isolates. Most of the ceftazidime resistant isolates from blood samples demonstrated multi-drug resistance. The high rate of resistance to extended spectrum beta-lactams, quinolones and aminoglycosides is a serious therapeutic challenge, as well as a significant factor for the outcome of blood stream infections caused by Enterobacter spp. In this study carbapenems and amikacin exhibit, the highest in vitro activity against Enterobacter spp., isolated from blood cultures with no resistance detected for carbapenems and 1.6% resistance for amikacin. Many authors report results that clearly demonstrate the advantage of carbapenem therapy for blood stream infections caused by ESBL - producing E. cloacae [27, 28]. In contrast to the urine and blood culture isolates, the isolates from wound secretions exhibit lower levels of resistance to most of the tested antimicrobials: ceftazidime 46.9%, gentamicin 42.9%, ciprofloxacin 31.1%, tetracycline 37.5%, trimethoprime/sulphometoxazole 31.6%, piperacillin/tazobactam 27.1%. In all three groups of isolates (blood, urine and wound secretions) the most active antimicrobial agents were carbapenems with fully preserved activity and amikacin with resistance levels varying between 1.6%, 4% and 6.9%. In conclusion, the studied collection of 433 isolates of Enterobacter spp. is associated with high levels of resistance to commonly used antimicrobial agents in the J of IMAB Oct-Dec;23(4)
5 clinical practice: piperacillin/tazobactam, ceftazidime, quinolones and gentamicin. In comparison to the whole studied group, ceftazidime resistant Enterobacter spp. demonstrated significantly higher levels of resistance to most of the tested antimicrobials as well as MDR phenotype. The highest level of ceftazidime resistant Enterobacter spp. was detected in the group of urine isolates. In the studied collection of isolates, the resistance to amikacin is the lowest, and the susceptibility to carbapenems is fully preserved. These antimicrobials are agents of the first choice in cases of severe infections caused by Enterobacter spp. or in cases of infections associated with MDR Enterobacter spp. Abbreviations: CAZ ceftazidime; TZP piperacillin/tazobactam; Gm gentamicin; Ak amikacin; T tetracycline; SXT - trimethoprime/sulphometoxazole; CIP ciprofloxacin; LVX levofloxacin; Acknowledgments: The study was funded by grant No.8383/ and contract No.D-59/ from Medical University - Sofia, Bulgaria. REFERENCES: 1. Mezzatesta ML, Gona F, Stefani S. Enterobacter cloacae complex: clinical impact and emerging antibiotical resistance. Future Microbiol Jul;7(7): [PubMed] 2. Sanders WE Jr, Sanders CC. Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin Microbiol Rev Apr;10(2): [PubMed] 3. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis Apr;197(8): [PubMed] 4. Davin-Regli A, Pagès JM. Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment. Front Microbiol May 18;6:392. [PubMed] 5. Jacoby GA. AmpC β-lactamases. Clin Microbiol Rev Jan; 22 (1): [PubMed] 6. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a Clinical Update. Clin Microbiol Rev Oct;18(4): [PubMed] 7. Rawat D, Nair D. Extended-spectrum β-lactamases in Gram Negative Bacteria. J Glob Infect Dis Sep; 2(3): [PubMed] 8. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat. Clin Microbiol Rev Oct;22(4): [PubMed] 9. Jacoby GA, Strahilevitz J, Hooper DC. Plasmid-mediated quinolone resistance. Microbiol Spectr. 2014; 2(2). [PubMed] 10. Rosii F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, et al. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother Jul;58(1): [PubMed] 11. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0, [Internet] 12. Xie J, Peters BM, Li B, Li L, Yu G, Xu Z, et al. Clinical features and antimicrobial resistance profiles of important Enterobacteriaceae pathogens in Guangzhou representative of Southern China, Microb Pathog Jun;107: [PubMed] 13. Maraki S, Vardakas KZ, Samonis G, Perdikis D, Mavromanolaki VE, Kofteridis DP, et al. In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece. Future Microbiol Jun;12: [PubMed] 14. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect Mar; 18(3): [PubMed] 15. Markovska RD, Stoeva TJ, Bojkova KD, Mitov IG. Epidemiology and Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Enterobacter spp., Pantoea agglomerans, and Serratia marcescens Isolates from a Bulgarian Hospital. Microbial Drug Resist Apr; 20(2): [PubMed] 16. Carattoli A. Resistance Plasmid Families in Enterobacteriaceae. Antimicrob Agents Chemoth Jun; 53(6): [PubMed] 17. Carattoli A. Plasmids in Gram negatives: Molecular typing of resistance plasmids. Int J Med Microbiol Dec; 301 (8): [PubMed] 18. Chmelnitsky I, Navon-Venezia S, Strahilevitz J, Carmeli Y. Plasmidmediated qnrb2 and carbapenemase gene bla(kpc-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates. Antimicrob Agents Chemother Aug;52(8): [PubMed] 19. Fernández J, Montero I, Martínez Ó, Fleites A, Poirel L, Nordmann P, et al. Dissemination of multiresistant Enterobacter cloacae isolates producing OXA-48 and CTX- M-15 in a Spanish hospital. Int J Antimicrob Agents Oct;46(4): [PubMed] 20. Miro E, Segura C, Navarro F, Sorli L, Coll P, Horcajada JP, et al. Spread of plasmids containing the blavim-1 and blactx-m genes and the qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and J of IMAB Oct-Dec;23(4)
6 Klebsiella oxytoca isolates. J Antimicrob Chemother Apr; 65(4): [PubMed] 21. Nilsen E, Haldorsen BC, Sundsfjord A, Simonsen GS, Ingebretsen A, Naseer U, et al. Large IncHI2-plasmids encode extendedspectrum b-lactamases (ESBLs) in Enterobacter spp. bloodstream isolates, and support ESBL-transfer to Escherichia coli. Clin Microbiol Infect Nov;19(11):E [PubMed] 22. Potron A, Poirel L, Bernabeu S, Monnet X, Richard C, Nordmann P. Nosocomial spread of ESBL-positive Enterobacter cloacae co-expressing plasmid-mediated quinolone resistance Qnr determinants in one hospital in France. J Antimicrob Chemother Sep; 64(3): [PubMed] 23. Shibl AM, Al-Agamy MH, Khubnani H, Senok AC, Tawfik AF, Livermoree DM. High prevalence of acquired quinolone-resistance genes among Enterobacteriaceae from Saudi Arabia with CTX-M-15 β-lactamase. Diagn Microbiol Infect Dis Aug; 73(4): [PubMed] 24. Wu JJ, Ko WC, Tsai SH, Yan JJ. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob Agents Chemother Apr;51(4): [PubMed] 25. Karlowsky JA, Hoban DJ, Hackel MA, Lob SH, Sahm DF. Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART Braz J Infect Dis May-Jun;21(3): [PubMed] 26. Karlowsky JA, Hoban DJ, Hackel MA, Lob SH, Sahm DF. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART J Med Microbiol Jan; 66(1):61-9. [PubMed] 27. Lee CC, Lee NY, Yan JJ, Lee HC, Chen PL, Chang CM, et al. Bacteremia due to extended-spectrumβ-lactamase-produsing Enterobacter cloacae : role of carbapenem therapy. Antimicrob Agents Chemother Sep;54(9): [PubMed] 28. Qureshi ZA, Paterson DL, Pakstis DL, Adams-Haduch JM, Sandkovsky G, Sordillo E, et al. Risk factors and outcome of extended-spectrum-β-lactamase-produsing Enterobacter cloacae bloodstream infections. Int J Antimicrob Agents Jan; 37(1): [PubMed] Please cite this article as: Dimitrova D, Stoeva T, Markovska R, Stankova P, Bozhkova M, Nedelcheva G, Mitov I. Antimicrobial susceptibility of clinically significant isolates of Enterobacter spp., obtained from patients, hospitalised in Varna University Hospital during the period J of IMAB Oct-Dec;23(4): DOI: Received: 29/08/2017; Published online: 18/12/2017 Address for correspondence Assoc. Prof. Temenuga Stoeva, MD, PhD Department of Microbiology and Virology, Medical University, Varna, 55, Marin Drinov Str., Varna, Bulgaria. temenuga.stoeva@abv.bg J of IMAB Oct-Dec;23(4)
Intrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL
ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationReceived: February 29, 2008 Revised: July 22, 2008 Accepted: August 4, 2008
J Microbiol Immunol Infect. 29;42:317-323 In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center
More informationWhat does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh
What does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh Disclosures Merck Research grant Clinical context of multiresistance Resistance to more classes of agents Less options
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More information2015 Antimicrobial Susceptibility Report
Gram negative Sepsis Outcome Programme (GNSOP) 2015 Antimicrobial Susceptibility Report Prepared by A/Professor Thomas Gottlieb Concord Hospital Sydney Jan Bell The University of Adelaide Adelaide On behalf
More informationTHE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS
THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be
More informationAntimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013
Antimicrobial Resistance Surveillance from sentinel public s, South Africa, 213 Authors: Olga Perovic 1,2, Melony Fortuin-de Smidt 1, and Verushka Chetty 1 1 National Institute for Communicable Diseases
More information2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationUpdate on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia. Po-Ren Hsueh. National Taiwan University Hospital
Update on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia Po-Ren Hsueh National Taiwan University Hospital Ventilator-associated Pneumonia Microbiological Report Sputum from a
More informationPrevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia
Prevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia Ruta Paberza 1, Solvita Selderiņa 1, Sandra Leja 1, Jelena Storoženko 1, Lilija Lužbinska 1, Aija Žileviča 2*
More informationMichael Hombach*, Guido V. Bloemberg and Erik C. Böttger
J Antimicrob Chemother 2012; 67: 622 632 doi:10.1093/jac/dkr524 Advance Access publication 13 December 2011 Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationInternational Journal of Pharma and Bio Sciences ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI ABSTRACT
Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI * PRABHAKAR C MAILAPUR, DEEPA
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More informationWitchcraft for Gram negatives
Witchcraft for Gram negatives Dr Subramanian S MD DNB MNAMS AB (Medicine, Infect Dis) Infectious Diseases Consultant Global Health City, Chennai www.asksubra.com Drug resistance follows the drug like a
More informationMechanism of antibiotic resistance
Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationAerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune
Original article Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Patil P, Joshi S, Bharadwaj R. Department of Microbiology, B.J. Medical College, Pune, India. Corresponding
More informationAntibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units
NEW MICROBIOLOGICA, 34, 291-298, 2011 Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units Vladimíra Vojtová 1, Milan Kolář 2, Kristýna Hricová 2, Radek Uvízl 3, Jan Neiser
More informationRETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR
Original article RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR R.Sujatha 1,Nidhi Pal 2, Deepak S 3 1. Professor & Head, Department
More informationMili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh
Detection of extended spectrum beta-lactamase producing Gram-negative organisms: hospital prevalence and comparison of double disc synergy and E-test methods Mili Rani Saha and Sanya Tahmina Jhora Original
More informationβ-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa March 2018
β-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa 12-14 March 2018 Antibiotic resistance center Institut Pasteur du Maroc Enterobacteriaceae (E. coli, Salmonella, ) S. aureus
More informationSurveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,
Original Article Vol. 28 No. 1 Surveillance of Antimicrobial Resistance:- Chaiwarith R, et al. 3 Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at
More informationDetection of Inducible AmpC β-lactamase-producing Gram-Negative Bacteria in a Teaching Tertiary Care Hospital in North India
Original Article Vol. 25 No. 3 Ampc β-lactamase Production in Gram-Negative Bacilli:-Chaudhary U, et al. 129 Detection of Inducible AmpC β-lactamase-producing Gram-Negative Bacteria in a Teaching Tertiary
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More information2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital
2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram
More information2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital
2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....
More informationESCMID Online Lecture Library. by author
Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA
More informationComparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria
Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development
More informationcrossm Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-negative pathogens between
RESEARCH ARTICLE Clinical Science and Epidemiology crossm Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Antibiotic Susceptibility Pattern of Pseudomonas Aeruginosa Isolated From Various Clinical
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationAntimicrobial Susceptibility Profile of E. coli Isolates Causing Urosepsis: Single Centre Experience
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 05 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.705.298
More informationMulti-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationFighting MDR Pathogens in the ICU
Fighting MDR Pathogens in the ICU Dr. Murat Akova Hacettepe University School of Medicine, Department of Infectious Diseases, Ankara, Turkey 1 50.000 deaths each year in US and Europe due to antimicrobial
More informationNosocomial Infections: What Are the Unmet Needs
Nosocomial Infections: What Are the Unmet Needs Jean Chastre, MD Service de Réanimation Médicale Hôpital Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie, Paris 6, France www.reamedpitie.com
More informationPrevalenceofAntimicrobialResistanceamongGramNegativeIsolatesinanAdultIntensiveCareUnitataTertiaryCareCenterinSaudiArabia
: K Interdisciplinary Volume 17 Issue 4 Version 1.0 Year 2017 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online ISSN: 2249-4618 & Print ISSN:
More informationBreaking the Ring. β-lactamases and the Great Arms Race. Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester
Breaking the Ring β-lactamases and the Great Arms Race Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester 2015 MFMER slide-1 Disclosures I have no relevant financial relationships
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationRecommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland
Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland A report by the Hospital Antimicrobial Stewardship Working Group, a subgroup of the
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationEUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)
EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) Christian G. Giske, MD/PhD Chairman of ESDReM Karolinska University Hospital and EUCAST ECCMID, 22 maj 2013 The background Guidance on
More informationDefining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing
Infect Dis Ther (2015) 4:513 518 DOI 10.1007/s40121-015-0094-6 BRIEF REPORT Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate
More informationC&W Three-Year Cumulative Antibiogram January 2013 December 2015
C&W Three-Year Cumulative Antibiogram January 213 December 215 Division of Microbiology, Virology & Infection Control Department of Pathology & Laboratory Medicine Contents Comments and Limitations...
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationInt.J.Curr.Microbiol.App.Sci (2017) 6(3):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104
More informationETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae
ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae Thomas Durand-Réville 02 June 2017 - ASM Microbe 2017 (Session #113) Disclosures Thomas Durand-Réville: Full-time Employee; Self;
More informationComparison of Susceptibility of Gram Negative Bacilli to Cephalosporins and Ciprofloxacin
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 9 (2016) pp. 205-212 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.509.023
More informationBacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India
ISSN: 2319-7706 Volume 4 Number 11 (2015) pp. 731-736 http://www.ijcmas.com Original Research Article Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching
More informationRESISTANT PATHOGENS. John E. Mazuski, MD, PhD Professor of Surgery
RESISTANT PATHOGENS John E. Mazuski, MD, PhD Professor of Surgery Disclosures Contracted Research: AstraZeneca, Bayer, Merck. Advisory Boards/Consultant: Allergan (Actavis, Forest Laboratories), AstraZeneca,
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
More informationComparison of Antibiotic Resistance and Sensitivity with Reference to Ages of Elders
Daffodil International University Institutional Repository DIU Journal of Science and Technology Volume 10, Issue 1-2, July 2015 2016-06-16 Comparison of Antibiotic Resistance and Sensitivity with Reference
More informationAvailable online at ISSN No:
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other
More informationAntimicrobial resistance of Escherichia coli urinary isolates in the Veterans Affairs Healthcare. System
AAC Accepted Manuscript Posted Online 13 February 2017 Antimicrob. Agents Chemother. doi:10.1128/aac.02236-16 Copyright 2017 American Society for Microbiology. All Rights Reserved. 1 2 Antimicrobial resistance
More informationOutline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010
Multi-Drug Resistant Organisms Is Combination Therapy the Way to Go? Sutthiporn Pattharachayakul, PharmD Prince of Songkhla University, Thailand Outline Prevalence of anti-microbial resistance in Acinetobacter
More informationOriginal Article. Suthan Srisangkaew, M.D. Malai Vorachit, D.Sc.
Original Article Vol. 21 No.1 The optimum agent for ESBL screening and confirmatory tests:- Srisangkaew S & Vorachit M. 1 The Optimum Agent for Screening and Confirmatory Tests for Extended-Spectrum Beta-Lactamases
More informationTaiwan Surveillance of Antimicrobial Resistance (TSAR)
Taiwan Surveillance of Antimicrobial Resistance (TSAR) 2009 MIRL Symposium July 17, 2009 Tsai-Ling Yang Lauderdale ( ) Microbial Infections Reference Laboratory (MIRL) Division of Infectious Diseases,
More informationANTIMICROBIAL RESISTANCE SURVEILLANCE FROM SENTINEL PUBLIC HOSPITALS, SOUTH AFRICA, 2014
ANTIMICROBIAL RESISTANCE SURVEILLANCE FROM SENTINEL PUBLIC HOSPITALS, SOUTH AFRICA, 2014 Olga Perovic, 1,2 Verushka Chetty 1 & Samantha Iyaloo 1 1 National Institute for Communicable Diseases, NHLS 2 Department
More informationSummary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
More informationDetection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from a Tertiary Care Centre, Bengaluru, India
ISSN: 2319-7706 Volume 4 Number 12 (2015) pp. 578-583 http://www.ijcmas.com Original Research Article Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from
More informationDetecting / Reporting Resistance in Nonfastidious GNR Part #2. Janet A. Hindler, MCLS MT(ASCP)
Detecting / Reporting Resistance in Nonfastidious GNR Part #2 Janet A. Hindler, MCLS MT(ASCP) Methods Described in CLSI M100-S21 for Testing non-enterobacteriaceae Organism Disk Diffusion MIC P. aeruginosa
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationEXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More information10/9/2012. Unprecedented success of antibiotics in 1960s. Infectious diseases are #1 cause of mortality worldwide
I have no conflicts of interest in relation to this program Whitney Jones, PharmD Antimicrobial Stewardship Pharmacist Vanderbilt University Medical Center October 25, 2012 Understand the epidemiology
More informationThe International Collaborative Conference in Clinical Microbiology & Infectious Diseases
The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of
More informationETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens
ETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens Ruben Tommasi, PhD Chief Scientific Officer ECCMID 2017 April 24, 2017 Vienna, Austria
More informationResearch & Reviews: Journal of Veterinary Sciences
Research & Reviews: Journal of Veterinary Sciences Antimicrobial Susceptibility Pattern of Gram Negative Bacteria Isolated from Feline Urinary Tract Infections (UTIs): A Retrospective Study from 2011 to
More informationClassification of drug resistance and novel single plate sensitivity testing to screen ESBL, AmpC, MBL in MDR, XDR and PDR isolates
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 10 Ver.III (Oct. 2015), PP 54-59 www.iosrjournals.org Classification of drug resistance and
More informationEducating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges
Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges Janet Hindler, MCLS MT(ASCP) UCLA Medical Center jhindler@ucla.edu also working as a consultant with the Association
More informationOriginal Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**
Original Article In Vitro Activity of Cefminox and Other β-lactam Antibiotics Against Clinical Isolates of Extended- Spectrum-β-lactamase-Producing Klebsiella pneumoniae and Escherichia coli Ratri Hortiwakul,
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationMolecular characterization of carbapenemase genes in Acinetobacter baumannii in China
Molecular characterization of carbapenemase genes in Acinetobacter baumannii in China F. Fang 1 *, S. Wang 2 *, Y.X. Dang 3, X. Wang 3 and G.Q. Yu 3 1 The CT Room, Nanyang City Center Hospital, Nanyang,
More informationORIGINAL ARTICLE ABSTRACT
ORIGINAL ARTICLE Increasing prevalence of extended-spectrum-betalactamase among Gram-negative bacilli in Latin America 28 update from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Authors
More informationA retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya
A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya LU Edirisinghe 1, D Vidanagama 2 1 Senior Registrar in Medicine, 2 Consultant Microbiologist,
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationDR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA
DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA The good old days The dread (of) infections that used to rage through the whole communities is muted Their retreat
More informationPrevalence of Ciprofloxacin Resistance Among Gram-Negative Bacilli at a Specialist Hospital in Saudi Arabia
Bangladesh Journal of Medical Science Vol. 11 No. 04 Oct 12 Original article Prevalence of Ciprofloxacin Resistance Among Gram-Negative Bacilli at a Specialist Hospital in Saudi Arabia Ahmad S Abstract:
More informationPROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains
PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains 1 INTRODUCTION... 1 2 OBJECTIVES... 2 3 OUTLINE OF THE EQAS 2017... 2 3.1 Shipping, receipt and storage of strains...
More informationInternational Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents 35 (2010) 227 234 Contents lists available at ScienceDirect International Journal of Antimicrobial Agents journal homepage: http://www.elsevier.com/locate/ijantimicag
More informationAcinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia.
Biomedical Research 12; 23 (4): 571-575 ISSN 97-938X Scientific Publishers of India Acinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia. Nazmul MHM, Jamal
More informationAcinetobacter Resistance in Turkish Tertiary Care Hospitals. Zeliha KOCAK TUFAN, MD, Assoc. Prof.
Acinetobacter Resistance in Turkish Tertiary Care Hospitals Zeliha KOCAK TUFAN, MD, Assoc. Prof. Acinetobacter Problem Countries that have reported hospital outbreaks of carbapenem-resistant Acinetobacter
More informationBACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)
BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016) VA Palo Alto Health Care System April 14, 2017 Trisha Nakasone, PharmD, Pharmacy Service Russell Ryono, PharmD, Public Health Surveillance
More informationPrevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India
International Journal of Current Microbiology and Applied Sciences ISSN: 319-77 Volume Number (17) pp. 57-3 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/1.5/ijcmas.17..31
More informationEpidemiology and Burden of Antimicrobial-Resistant P. aeruginosa Infections
Epidemiology and Burden of Antimicrobial-Resistant P. aeruginosa Infections Keith S. Kaye, MD, MPH Professor of Medicine Division of Infectious Diseases Department of Internal Medicine University of Michigan
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationRCH antibiotic susceptibility data
RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological
More informationGeorgios Meletis, Efstathios Oustas, Christina Botziori, Eleni Kakasi, Asimoula Koteli
New Microbiologica, 38, 417-421, 2015 Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin
More information